Table 1.
Patient Characteristics
| EUS-GBD (n=10) | PTGBD (n=11) | PTGBA (n=27) | |
|---|---|---|---|
| Age, mean±SD, yr | 71±10 | 77±11 | 71±10 |
| Sex, male (n) | 70% (7) | 73% (8) | 67% (18) |
| Etiology (n) | |||
| Pancreatic cancer | 50% (5) | 45% (5) | 74% (20) |
| Distal bile duct cancer | 20% (2) | 0 (0) | 7% (2) |
| Perihilar bile duct cancer | 30% (3) | 27% (3) | 15% (4) |
| Gallbladder cancer | 0 (0) | 18% (2) | 0 (0) |
| Metastatic lymph nodes | 0 (0) | 9% (1) | 4% (1) |
| CCI, mean (range) | 3.6 (2–8) | 4.8 (2–8) | 4.5 (2–9) |
| ECOG scale, mean (range) | 1.5 (0–3) | 0.9 (0–3) | 1.0 (0–3) |
| Severity grading for acute cholecystitis (n) | |||
| Grade I (mild) | 20% (2) | 9% (1) | 22% (6) |
| Grade II (moderate) | 40% (4) | 27% (3) | 63% (17) |
| Grade III (severe) | 40% (4) | 64% (7) | 15% (4) |
CCI, Charlson comorbidity index; ECOG, Eastern Cooperative Oncology Group; EUS-GBD, endoscopic ultrasonography-guided gallbladder drainage; PTGBA, percutaneous transhepatic gallbladder aspiration; PTGBD, percutaneous transhepatic gallbladder drainage; SD, standard deviation.